St. Louis surgical instrument maker to start listing on NYSE American

St. Louis-based surgical instrument maker Stereotaxis said Tuesday that it has been approved to list its stock on the NYSE American exchange. The company, which develops robotic technologies designed for the treatment of arrhythmias and to perform endovascular procedures, will start trading on the NYSE American exchange on Sept. 6. It will keep its current symbol “STXS.” “We are excited to list on the NYSE American. This is anot her milestone in our effort to improve awareness of our differentiated…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news